Ordering Recommendation

Confirm toxoplasmosis infection in immunocompromised hosts as well as fetuses and newborns. May be used to confirm equivocal antibody testing.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

Lavender (EDTA), pink (K2EDTA) or serum separator tube. OR Amniotic fluid, CSF, ocular fluid or tissue.

Specimen Preparation

Separate serum or plasma from cells. Transfer 1 mL serum, plasma, amniotic fluid, CSF or ocular fluid to a sterile container. (Min: 0.5 mL) OR Tissue: Transfer to a sterile container and freeze immediately.

Storage/Transport Temperature


Unacceptable Conditions

Heparinized specimens, tissues in optimal cutting temperature compound.


Specimen source required.


Tissue: Ambient: Unacceptable; Refrigerated: Unacceptable; Frozen: 3 months
All Others: Ambient: 8 hours; Refrigerated: 5 days;  Frozen: 3 months


Qualitative Polymerase Chain Reaction


Tue, Fri


1-5 days

Reference Interval

Interpretive Data

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.

Compliance Category

Laboratory Developed Test (LDT)


Hotline History


CPT Codes



Component Test Code* Component Chart Name LOINC
0050112 Toxoplasma gondii Source 31208-2
0055591 Toxoplasma gondii by PCR 29904-0
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.


  • Coccidia
  • T gondi DNA detection
  • T. gondii PCR
  • Toxoplasma gondii, Molecular Detection, PCR
Toxoplasma gondii by PCR